An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

A recent study has found that dronabinol, a synthetic version of THC (the primary psychoactive component in cannabis), ...

Cognitive decline may increase an older person's risk for a fall, while the trauma that follows a fall may also speed up ...

Agitation is one of the most distressing symptoms of Alzheimer's dementia, and we are pleased to make positive strides forward in treatment of these patients." Paul Rosenberg, M.D., professor of ...

"It is the agitation, not the memory loss, that often drives individuals with dementia to the emergency ... needed to better understand predictors of treatment response to help inform subsequent ...

Anxiety and depression are significant risk factors for AD, and conversely, AD increases the likelihood of developing these psychiatric conditions. A systematic review of 14,760 studies showed ...